Price: $0 OnDemand
Sign up today for an entire year of unlimited access to relevant, timely professional learning courses, including webinars, eLearning courses and OnDemand offerings, and keep your professional credits up to date. All for just $399.SUBSCRIBE NOW
Mr. Jon Glaudemans is a managing director of Manatt Health Solutions, an interdisciplinary policy and business advisory practice of Manatt, Phelps & Phillips, LLP. Mr. Glaudemans has more than 30 years of senior leadership experience in health care operations, policy issues management, financial analysis, communications and health insurance. His areas of focus include insurance regulation, payer-provider market dynamics, provider payment policy, e-health, health plan administration, health disparities and quality improvement initiatives across a variety of care settings.
Prior to joining Manatt, Mr. Glaudemans was Chief Advocacy Communications Officer at Ascension Health, the nation’s largest nonprofit healthcare system, with over 120 hospitals in more than 20 states. He spent five years as the Senior Vice President/Chief Operating Officer at Avalere Health, LLC, a Washington-based advisory group. In 2001, Mr. Glaudemans was asked to serve as Co-Transition Coordinator for the incoming Administrator for the Centers for Medicare and Medicaid Services, where he played a leadership role in designing and initiating the first federally sponsored prescription drug discount program. He spent at decade at Aetna, where his roles included General Manager of Aetna U.S. Healthcare’s Mid-Atlantic Region. Mr. Glaudemans began his career at the U.S. Office of Management and Budget (OMB), where he was intimately involved in Medicare budget, regulatory and legislative initiatives.
Mr. Glaudemans earned his M.P.A. from the Princeton University Woodrow Wilson School and his B.S. from the Massachusetts Institute of Technology.
Mr. Andrew Rudman is a Managing Director with ManattJones Global Strategies. Based in the firm’s Washington, D.C. office, Mr. Rudman leads ManattJones’ health care practice and counsels clients in the pharmaceutical, medical device and nutritional supplement sectors on regulatory and public policy challenges related to market entry and market access in the Americas. He writes and speaks on Mexican health care issues, including systemic reform and public-private sector collaboration. Mr. Rudman has experience in public policy and advocacy on behalf of the private sector and has worked extensively in Latin America as well as Canada and Russia. Mr. Rudman has represented the biopharmaceutical industry before various domestic and foreign government entities and regulators, interest groups and academia and has successfully coordinated major trade and foreign policy initiatives. As a former Foreign Service Officer and senior member of the Department of Commerce’s International Trade Administration, he has also advocated for U.S. companies in foreign markets.
Prior to joining the firm, Mr. Rudman was the Deputy Vice President for the Western Hemisphere of Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to joining PhRMA, Mr. Rudman was Director of the Office of NAFTA and Inter-American Affairs at the U.S. Department of Commerce. He began his government career as a Foreign Service Officer in the U.S. Department of State.
Mr. Rudman earned his M.A. from Tulane University and his B.A., cum laude, from Colby College.
Ms. Linda Tiano has more than 30 years of health law experience. Her practice focuses on providing regulatory and transactional guidance to health care providers, primarily in the managed care segment. Her clients include health insurance companies; managed care plans, including Medicare, Medicaid and commercial health plans; health plan co-ops; health care providers, including hospitals and large physician organizations; and third-party vendors, including specialty networks and care management firms.
Ms. Tiano advises clients on alignment initiatives between hospitals and health plans, including joint ventures and value-based payment arrangements and the establishment and operation of Accountable Care Organizations (ACOs) and Physician-Hospital Organizations (PHOs), as well as other types of networks; health reform implementation; governance issues; compliance programs and reviews relating to state and federal laws; and the regulatory and transactional aspects of mergers and acquisitions, joint ventures, strategic affiliations and other health care business arrangements. She also drafts and negotiates major contractual arrangements, including business process outsourcing, Integrated Delivery Systems, ACOs and innovative payment agreements. In addition, she counsels early-stage health-related investors on the terms, conditions and risks related to their investments.
Ms. Tiano joined Manatt from a major national law firm, where she was a member of the Healthcare and Life Sciences practice. Prior to her work at the law firm, she was an executive and general counsel of both nonprofit and public health insurance companies for almost 20 years.
Ms. Tiano is admitted to practice in the District of Columbia and New York, before the New York Supreme Court, and federal courts in the Southern and Northern Districts of New York. Ms. Tiano earned her J.D., cum laude, from Boston University School of Law and her B.A., summa cum laude, from University of Cincinnati.
Dr. Alfonso Vargas Rodriguez, MD, has been a member of the Executive Team of H+ since 2012, initially as head of Medical Liaison and then as Chief Medical and Operations Officer. Prior to joining H+, Dr. Vargas worked in Medica Sur SAB de CV, the only hospital in Mexico listed in the Mexican Stock Exchange. At Medica Sur, he worked as Chief Medical Officer and Chief Executive Officer of Clinica Medica Sur, a subsidiary within Medica Sur. His most recent position was as Chief Communication Officers, where he was responsible for the Medical Credentials Committee. Dr. Vargas studied Medicine at the Universidad La Salle and is Board Certified in Internal Medicine with a sub-specialization in Rheumatology. In addition, he has a diploma in Hospital Administration and Finance from UNAM.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)